Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ELAVIL | AstraZeneca | N-012703 DISCN | 1982-01-01 | 6 products, RLD |
ELAVIL | AstraZeneca | N-012704 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TRIAVIL 2-25 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
TRIAVIL 4-10 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
TRIAVIL 2-10 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
TRIAVIL 4-25 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
TRIAVIL 4-50 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
ETRAFON-A | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
ETRAFON 2-25 | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
ETRAFON-FORTE | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
ETRAFON 2-10 | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LIMBITROL | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
LIMBITROL DS | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
amitriptyline | ANDA | 2021-04-20 |
amitriptyline hcl | ANDA | 2024-10-04 |
amitriptyline hydrochloride | ANDA | 2024-11-18 |
chlordiazepoxide & amitriptyline hydrochloride | 2007-02-12 | |
chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2024-02-15 |
chlordiazepoxide and amitriptyline hydrochloride chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2024-11-12 |
elavil | ANDA | 2021-08-31 |
elavil 25 mg | ANDA | 2016-04-13 |
perphenazine and amitriptyline hydrochloride | ANDA | 2024-11-15 |
sentravil pm-25 | unapproved drug other | 2011-08-01 |
Code | Description |
---|---|
J1320 | Injection, amitriptyline hcl, up to 20 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | 1 | — | — | 1 |
Drug common name | Amitriptyline |
INN | amitriptyline |
Description | Amitriptyline is an organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5. It has a role as an adrenergic uptake inhibitor, an antidepressant, an environmental contaminant, a xenobiotic and a tropomyosin-related kinase B receptor agonist. It is a tertiary amine and a carbotricyclic compound. It derives from a hydride of a dibenzo[a,d][7]annulene. |
Classification | Small molecule |
Drug class | antidepressants (dibenzol[a,d]cycloheptane derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)CCC=C1c2ccccc2CCc2ccccc21 |
PDB | — |
CAS-ID | 50-48-6 |
RxCUI | — |
ChEMBL ID | CHEMBL629 |
ChEBI ID | 2666 |
PubChem CID | 2160 |
DrugBank | DB00321 |
UNII ID | 1806D8D52K (ChemIDplus, GSRS) |